Skip to main content

Table 1 Studies regarding blood transfusion in head and neck cancer patients

From: An evaluation of the preoperative hemoglobin level as a prognostic factor for oral squamous cell carcinoma

Author Patients (n) Location Outcome Results
Böck[24] 174
(141 with transfusion)
Larynx/hypopharynx Recurrence, survival, infection No influence
Jones[25] 90
(46 with transfusion)
Head and neck Recurrence No influence
Ell[26] 240
(113 with transfusion)
Larynx Survival No influence
Woolley[27] 143
(99 with tranfusion)
Head and neck Recurrence P < 0.009
Von Doersten[28] 104
(51 with transfusion)
Head and neck Recurrence, infection No influence
Schuller[17] 217
(132 with transfusion)
Head and neck Survival No influence
Barra[29] 207
(152 with transfusion)
Head and neck Survival P < 0.05
Alun-Jones[30] 69
(38 with transfusion)
Larynx Survival P < 0.05
Sturgis[14] 61
(25 with transfusion)
Head and neck Recurrence Influence
(48% with transfusion; 24% without transfusion)
Leon[31] 269
(86 with transfusion)
Larynx Recurrence No influence
Moir[32] 165 (60 with transfusion) Head and neck Recurrence P < 0.04
Taniguchi[15] 105
(64 with transfusion)
Oral cavity Survival P < 0.01
Szakmany[33] 559
(437 with transfusion)
Oral cavity/
Oropharyngeal
Recurrence,
survival
≥3 units influence
Fenner[16] 223 Oral cavity Survival No influence
  1. Studies involving the effects of blood transfusion in head and neck cancer show inconsistent results